Overview

Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

Status:
Not yet recruiting

Trial end date:
2023-10-15

Target enrollment:

Participant gender:

Summary

The researchers collect H.pylori-positive patients who need rescue therapy from the outpatient clinic. The subjects were randomized to receive a dose and frequency of tetracycline 500mg tid or qid of bismuth quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates and patient compliance of each group.

Phase:

Phase 4

Details

Lead Sponsor:

Shandong University

Collaborators:

PKUcare luzhong hospital
Taierzhuang District People's Hospital
Yuncheng Hospital of Traditional Chinese Medicine
Zhengzhou Central Hospital
Zibo Central Hospital

Treatments:

Amoxicillin
Bismuth
Esomeprazole
Tetracycline